maintenance glp 1 A Practical GLP-1 Aftercare Handbook GLP-1 Maintenance: The Next Step

BPC-157 and TB-500 are not FDA-approved for human use, and their safety and effectiveness in women have not been established

Common side effects include: Gastrointestinal issues: Nausea, vomiting, constipation, and abdominal pain Injection site reactions: Redness, swelling, and pain Systemic issues: Fatigue, indigestion, heartburn, belching, and hair loss More severe side effects include: Thyroid problems: Medullary thyroid cancer and pancreatitis with severe, persistent abdominal pain Gallbladder problems with symptoms such as upper abdominal pain, fever, jaundice, or clay-colored stools Increased risk of hypoglycemia with symptoms such as dizziness, sweating, confusion, and shakiness Severe vomiting that leads to dehydration and kidney problems Mental health concerns such as depression and suicidal thoughts Vision changes from rapid changes in blood glucose levels Some patients should not use Zepbound, such as those who have or are at risk for medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

All three programs in this comparison let you communicate with the prescribing clinician through their platform, so you can report side effects and adjust dose without paying for an extra visit

Patients who come in with one concern often stay because we treat their skin like a long-term relationship, not a single transaction

After injecting BAC water, the vial often holds positive pressure that makes future draws harder